Results for
"[search-keyword]"
Sponsor content
162 result(s) found, displaying 1 to 10
-
Australian Public Assessment Report (AusPAR)Wegovy has been approved for weight management in obese adolescents ages 12 years and above (as an adjunct to a reduced-calorie diet and increased physical activity).
-
Australian Public Assessment Report (AusPAR)Wegovy (semaglutide)has been approved as an adjunct to a reduced-energy diet and increased physical activity for chronic weight management (including weight loss and weight maintenance) in adults.
-
Prescription medicine registrationActive ingredients: nonacog beta pegol.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for AWIQLI insulin icodec 2100 U in 3 mL solution for injection pre-filled pen with disposable needles.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for AWIQLI insulin icodec 2100 U in 3 mL solution for injection pre-filled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for AWIQLI insulin icodec 1050 U in 1.5 mL solution for injection pre-filled pen with disposable needles.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for AWIQLI insulin icodec 1050 U in 1.5 mL solution for injection pre-filled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for AWIQLI insulin icodec 700 U in 1 mL solution for injection pre-filled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for AWIQLI insulin icodec 700 U in 1mL solution for injection pre-filled pen with disposable needles.
-
Prescription medicine decision summaryAwiqli (insulin icodec) has been approved for the treatment of type 1 and type 2 diabetes in adults.